Technical Program

Plenary Session
Sunday, 1 June
12:00 - 18:00
Registration
18:00
ORG-1 : Welcome and Introduction
Bob Snyder, ICCS Program Chair
18:15

Opening Session - Keynote Address, CSA Trust Mike Lynch Award
K-1 : Challenges/opportunities for chemical structure databases in the 21st century
Alexander J. Lawson, Elsevier Information Systems, Frankfurt
Presentation (2.5 MB)

19:00
Welcoming Reception – Atrium, courtesy of CCDC
20:00
Rijsttafel Dinner – Atrium, courtesy of Chemical Abstracts Service (CAS)
Monday, 2 June
08:30 - 10:30

Informatics for Bridging Between Chemistry and Biology
Kimito Funatsu, Presiding

08:30 - 09:00

A-1 : Protein target prediction of toxic molecules identifies toxicological relationships Between proteins
Florian Nigsch, University of Cambridge

09:00 - 09:30
A-2 : Exploiting systems chemical biology to predict and understand (un)desired drug effects
Josef Scheiber, Novartis Institutes for Biomedical Research
Presentation (2.4 MB)
09:30 - 10:00
A-3 : Binding site similarity analysis for the functional classification of the protein kinase family
Richard M. Jackson, University of Leeds
10:00 - 10:30
A-4 : Merging high-content screening and in silico approaches for compound profiling and mode-of-action analysis
Andreas Bender, Leiden / Amsterdam Center for Drug Research
10:30 - 11:00
Break
11:00 - 15:00
Cheminformatics
Lothar Terfloth, Presiding
11:00 - 11:30
B-1 : Performance of common similarity measures in virtual screening and lead-hopping
J Christian Baber, Wyeth Research
11:30 - 12:00
B-2 : Maximum unbiased validation (MUV) of ligand based virtual screening
Knut Baumann, University of Technology Braunschweig
12:00 - 12:30
B-3 : Molecular similarity by pattern recognition: Fast calculation of 3D pharmacophore resemblence
Gerhard Wolber, Inte:Ligand GmbH
12:30 - 13:30
Lunch
13:30 - 14:00
B-4 : Analysis of natural products: Lessons from nature inspiring the design of new drugs
Peter Ertl, Novartis Institutes for BioMedical Research
14:00 - 14:30
B-5 : It's all in the bits: Improved database searching with better bits
Harold Helson, CambridgeSoft Inc.
Presentation (0.4 MB)
14:30 - 15:00
B-6 : Is there a general model for bioactivity?
Tudor I. Oprea, University of New Mexico
Presentation (0.9 MB)
15:00 - 15:30
Break
15:00 - 19:30
Exhibition & Posters
15:30 - 17:30
Poster Presentations ( odd-numbered poster authors present)
18:30 - 19:30
Reception
19:30 - 21:30
Dinner
Tuesday, 3 June
08:30 - 15:00
Structure-Based Drug Design and Virtual Screening
Val Gillet, Presiding
08:30 - 09:00
C-1 : SAMPL: Statistical assessment of the modeling of proteins and ligands
A. Geoffrey Skillman, OpenEye Scientific Software
09:00 - 09:30

C-2 : HYDE: An integrated description of dehydration and H-bonding within protein ligand interfaces
Gudrun Lange, Bayer CropScience
Presentation (1.5 MB)

09:30 - 10:00
C-3 : Specificity scoring
Joannis Apostolakis, LMU Munich / MoDeST
10:00 - 10:30
C-4 : Flexophore, a new versatile 3D pharmacophore descriptor
Modest von Korff, Actelion Ltd.
10:30 - 11:00
Break
11:00 - 11:30
C-5 : A fragment-based computational protocol at PDB scale - Application to lead-optimization of DFG-out kinase inhibitors
Thomas Henry, MEDIT
Presentation (0.9 MB)
11:30 - 12:00
C-6 : Can 3D ligand based virtual screening compete with docking? Application of molecular fields to virtual screening with the DUD dataset
Mark Mackey, Cresset BioMolecular Discovery Limited
Presentation (0.7 MB)
12:00 - 12:30
C-7 : Novel fragment-like PTR1 inhibitors discovered by virtual screening
Chido Mpamhanga, Dundee University (Drug Dicovery Unit)
12:30 - 12:45
Group Photo
12:30 - 13:30
Lunch
13:30 - 14:00
C-8 : Fleksy: a flexible approach to induced fit docking
Sander B. Nabuurs, Radboud University Nijmegen
14:00 - 14:30
C-9 : Index-driven structure-based virtual screening
Jochen Schlosser, Center for Bioinformatics Hamburg (ZBH)
14:30 - 15:00
C-10 : Algorithmic design of ligand binding pockets on protein surfaces
Susanne Eyrisch, Center for Bioinformatics, Saarland University
15:00 - 15:30
Break
15:00 - 19:30
Exhibition & Posters
15:30 - 17:30
Poster Presentations (even-numbered poster authors present)
18:30 - 19:30
Reception
19:30 - 21:30
Dinner
Wednesday, 4 June
08:30 - 10:30
Virtual Chemistry
Markus Wagener, Presiding
08:30 - 09:00
D-1 : De novo drug design using multi-objective evolutionary graphs
Christos Nicolaou, University of Cyprus
Presentation (0.6 MB)
09:00 - 09:30
D-2 : Planning organic synthesis using reaction types derived from reaction databases
Christof H. Schwab, Molecular Networks GmbH
Presentation (0.6 MB)
09:30 - 10:00
D-3 : Knowledge-based de novo design using reaction vectors
Hina Patel, University of Sheffield
Presentation (0.5 MB)
10:00 - 10:30
D-4 : Recore: Instant 3D scaffold hopping using replacement fragments
Peter Richard Oledzki, BioSolveIT
Presentation (2.5 MB)
10:30 - 11:00
Break
11:00 - 13:00
Analysis of Large Data Sets
Christoph Steinbeck, Presiding
11:00 - 11:30
E-1 : Turns revisited: Clustering turn structures using ESOMs leads to a uniform classification for open, normal and reverse turn families
Oliver Koch, The Cambridge Crystallographic Data Centre
Presentation (4.0 MB)
11:30 - 12:00
E-2 : Searching fragment spaces with feature trees
Uta Lessel, Boehringer Ingelheim Pharma GmbH & Co. KG
Presentation (0.3 MB)
12:00 - 12:30
E-3 : Three way comparison of chemical spaces avoiding structure exchange
Jens Loesel, Pfizer
Presentation (0.4 MB)
12:30 - 13:00

E-4 : Use of data mining to help identify compounds that are unstable in DMSO
Jameed Hussain, GlaxoSmithKline
Presentation (0.4 MB)

13:00 - 13:00
Box Lunch
13:00 - 23:00
Excursion to Amsterdam, dinner courtesy of Chemical Computing Group (CCG)
Thursday, 5 June
07:30 - 08:30
Hotel Check-out
08:30 - 13:00
Structure-Activity and Structure-Property Prediction
Matthias Rarey, Presiding
08:30 - 09:00
F-1 : CypScore - in silico case studies on metabolic stability optimization
Andreas H. Göller, Bayer Healthcare AG
Presentation (0.9 MB)
09:00 - 09:30
F-2 : SyGMa: combining 2 knowledge and empirical scoring in the prediction of metabolites
Lars Ridder, Organon, a part of Schering-Plough Corporation
Presentation (0.6 MB)
09:30 - 10:00

F-3 : TopoHERG – A highly selective pharmacophoric classifier for hERG-channel active compounds
Britta Nisius, Bayer Healthcare AG
Presentation (0.5 MB)

10:00 - 10:30
F-4 : Compound set optimization and sequential screening using emerging chemical patterns
Jens Auer, Bonn-Aachen International Center for Information Technology
10:30 - 11:00
Break and Hotel Check-out
11:00 - 11:30

F-5 : Interpretable Activity Models: exploring the limits of pharmacophore and 3D QSAR methods
David Anthony Evans, Eli Lilly

11:30 - 12:00

F-6 : QSAR modeller seeks meaningful relationship
Craig L. Bruce, University of Nottingham
Presentation (1.7 MB)

12:00 - 12:30

F-7 : Rational design of M1-Muscarinic Antagonists using combinatorial transformation
Michael B. Bolger, Simulations Plus, Inc.
Presentation (1.2 MB)

12:30 - 13:00
F-8 : Structure-activity landscapes: a new way to study a structure-activity relationship
John H van Drie, John H Van Drie Research LLC
13:00 - 13:15
Closing Remarks
Markus Wagener, ICCS Vice Chair
13:15 - 14:00
Lunch or Box Lunch
13:30 - 14:00
Shuttle buses leave for Schiphol Airport
14:30 - 15:00
Shuttle buses leave for Schiphol Airport
 
BioSolveIT Workshop
14:00 - 17:00
Interactive Workshop on Virtual Screening and De Novo Design by BioSolveIT GmbH (registration with BioSolveIT required)
17:00 - 17:30
Shuttle bus leaves for Schiphol Airport
 
Poster Session
P-1 : Discovery Portal - a novel tool to increase productivity, efficiency and transparency across R&D organizations
Jaroslaw Tomczak, Accelrys
P-2 : A simple language for conversing between diverse applications
Omara Williams, Accelrys
P-3 : The use of stereo descriptors in the context of a structure validation workflow
Omara Williams, Accelrys
Presentation (1.0 MB)
P-4 : OSIRIS, an entirely in-house developed drug discovery informatics system
Thomas L Sander, Actelion Pharmaceuticals Ltd.
Presentation (1.9 MB)
P-5 : Scientific database application without borders: Empowering the scientists
Man-Ling Lee, Aestel Scientific Information, LLC
Presentation (0.9 MB)

P-6 : Diversity oriented virtual compound selection strategy for high throughput screening of potential anticancer agents
Gyorgy Dorman, AMRI

P-7 : Investigating false predictions in mutagenicity QSAR models: What are we missing?
Catrin Hasselgren, AstraZeneca
P-8 : Selecting druglike pieces for the jigsaw puzzle: towards optimal fragment spaces
Christof Gerlach, Bayer Schering Pharma
P-9 : Going on SARfari in the protein kinase data jungle
Judith Günther, Bayer Schering Pharma
P-10 : A probabilistic approach to classifying metabolic stability
Antonius ter Laak, Bayer Schering Pharma
Presentation (0.4 MB)
P-11 : MCS clustering - A hierarchical clustering approach for large data sets
Alexander Böcker, Boehringer Ingelheim
P-12 : Comparison of different approaches for cytochrome P450 modeling
Paul Czodrowski, Boehringer Ingelheim
P-13 : Mapping of activity class characteristic substructures extracted from random fragment populations
Eugen Lounkine, Bonn-Aachen International Center for Information Technology
Presentation (0.5 MB)
P-14 : In silico prediction of efflux substrates classification
Litai Zhang, Bristol Myers Squibb
P-15 : Digging deep for GOLD - Using buriedness to improve discrimination between actives and inactives in docking
Noel M. O'Boyle, Cambridge Crystallographic Data Centre
Presentation (0.3 MB)
P-16 : Representation, searching and enumeration of generic structures – From molecules towards patents
Szabolcs Csepregi, ChemAxon Ltd.
P-17 : Hierarchical clustering of chemical structures by learned scaffolds
Miklos Vargyas, ChemAxon Ltd.
Presentation (0.9 MB)

P-18 : Molecular framework based analysis of large chemical spaces
Anthony Joseph Trippe, Chemical Abstracts Service
Presentation (0.8 MB)

P-19 : Towards automated searching of data in Internet chemical databases
Xiaoxia Li, Chinese Academy of Sciences
P-20 : Chemotype bias in virtual screening: the elephant in the room
Mark Mackey, Cresset BioMolecular Discovery Limited
Presentation (2.5 MB)
P-21 : Rapid property profiling and similarity calculations in large virtual libraries
John Mordaunt Barnard, Digital Chemistry Ltd
P-22 : Opportunities for integrating Markush patent searching with drug discovery
John Mordaunt Barnard, Digital Chemistry Ltd
P-23 : A mathematically more precise taxonomy and nomenclature for polymers
Seymour Benjamin Elk, Elk Technical Associates
P-24 : Indirect drug design using MD for flexible structure alignment application to HIV-1 protease inhibitors
Alok Juneja, Freie Universität
P-25 : Optimizing drug classification by feature selection: To bind or not to bind that is the question
Ernst-Walter Knapp, Freie Universität
P-26 : Understanding selective CDK4 inhibition through molecular dynamics
Nahren Manuel Mascarenhas, Indian Institute of Chemical Biology
P-27 : Extracting chemical CYP proteins interactions from literature using natural language processing methods
Dazhi Jiao, Indiana University

P-28 : An infrastructure for data mining public chemical & biological information
David J Wild, Indiana University
Presentation (1.5 MB)

P-29 : Binding affinity prediction of distinct inhibitors of group-1 and group-2 Neuraminidases (NAs): ArgusLab4/AScore protocol
Marija L. Mihajlovic, Institute for Multidisciplinary Research
P-30 : Prediction of novel drug targets in the metazoan parasite schistosoma mansoni
Frank Oellien, Intervet Innovation GmbH
P-31 : Performance of different machine learning methods
Uwe Koch, IRBM Merck Research Laboratories
P-32 : Assessing and exploiting non-additivity in a structure-activity relationship
John H van Drie, John H Van Drie Research LLC
P-33 : CLiDE Pro: A chemical OCR tool
Aniko Tunde Valko, Keymodule Ltd.
P-34 : Molecular subgraph mining for analyzing ligand activity classes
Julio E. Peironcely, LACDR
P-35 : Frequent Substructure Mining of GPCR ligands
Eelke van der Horst, Leiden University
P-36 : Characterization of the inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors and proteochemometric models which are able to predict compound activity against particular target mutants
Gerard Jacob Pieter van Westen, Leiden University

P-37 : Consensus modeling of chemical biodegradation pathways
ML Patel, Lhasa Limited
Presentation (0.4 MB)

P-38 : Scaffold hunter: Exploiting holes in chemical space
Stefan Wetzel, Max-Planck Institute for Molecular Physiology

P-39 : Dynamic web application for drug design research
Mitchell Scott Chapman, Mesa Analytics & Computing
Presentation (1.7 MB)

P-40 : Parallel tiered clustering for large data sets using a modified Taylor’s algorithm
John David MacCuish, Mesa Analytics & Computing
Presentation (1.2 MB)
P-41 : Ligand-based models for the isoform specificity of Cytochrome P450 substrates
Lothar Terfloth, Molecular Networks GmbH
P-42 : Metabolomics approach for determining growth-specific metabolites based on Fourier transform ion cyclotron resonance mass spectrometry
Hiroki Takahashi, Nara Institute of Science and Technology
P-43 : Clustering peptidases emplying structural features of their inhibitors
Mariusz Milik, Novartis Institutes for Biomedical Research
Presentation (0.4 MB)
P-44 : Prediction of cell permeability
Paul Selzer, Novartis Institutes for Biomedical Research
Presentation (0.3 MB)

P-45 : Validation using the RCSB: Good idea or bad idea?
Paul Charles Hawkins, OpenEye Scientific
Presentation (0.3 MB)

P-46 : Automated generation of fragment-based rules for mutagenicity prediction
Olaf Günter Othersen, Radboud University Nijmegen
Presentation (0.9 MB)
P-47 : The detection of new active site conformations using molecular dynamics and rotamer assignments
Gijs Schaftenaar, Radboud University Nijmegen
P-48 : Automated extraction of kinase hinge-binding fragments from the protein data bank
Dave John Wood, Radboud University Nijmegen
P-49 : Get the best from substructure mining
Jeroen Kazius, Research For Charity Foundation
P-50 : The RSC's Project Prospect: identification and reuse of chemistry in publications
Richard Kidd, Royal Society of Chemistry
P-51 : In silico studies on P63 as a new drug-target protein
Anna Karawajczyk, RUMC
P-52 : QSAR modelling of antineoplastic activities using NIH Roadmap Data
Alexey Zakharov, Russian Academy of Medical Science
P-53 : GUSAR: new approach for multiple QSAR
Alexey Zakharov, Russian Academy of Medical Science
P-54 : Fast empirical estimates of quantum mechanical descriptors for QSAR/QSPR modeling
Robert Fraczkiewicz, Simulations Plus, Inc.
Presentation (4.0 MB)
P-55 : The representation, registration, and retrieval of substances with incompletely defined chemical structures
Keith T Taylor, Symyx Technologies Inc
P-56 : Exploring synthetically accessible chemical space
Keith T Taylor, Symyx Technologies Inc
P-57 : Development and visualization of the drug-likeness model
Masamoto Arakawa, The University of Tokyo
Presentation (0.7 MB)
P-58 : Reverse analysis and multi-objective optimization of predictive models for polymer properties
Shun Goto, The University of Tokyo
Presentation (0.1 MB)
P-59 : Development of a new regression analysis method using independent component analysis
Hiromasa Kaneko, The University of Tokyo
Presentation (0.1 MB)
P-60 : Rule Induction of the site of metabolism by human Cytochromes P450 by data-mining
Michio Koyama, The University of Tokyo
P-61 : Dynamic interplay between chemotype, similarity and docking studies: Towards a virtual screening approach for protein kinase B inhibitors
Jose L. Medina-Franco, Torrey Pines Institute for Molecular Studies
Presentation (9.1 MB)
P-62 : Multi-fusion similarity maps for comparing the chemical space of compound databases
Jose L. Medina-Franco, Torrey Pines Institute for Molecular Studies
Presentation (0.7 MB)
P-63 : The effect of structural redundancy on virtual screen performance
Robert D. Clark, Tripos International
Presentation (0.4 MB)

P-64 : Topomer CoMFA for rapid optimization
Bernd Wendt, Tripos International
Presentation (0.8 MB)

P-65 : Development of an a priori ionic liquid design tool: Integration of a novel COSMO-RS molecular descriptor on neural networks
Jose Palomar, Universidad Autónoma de Madrid
P-66 : Radial scan of the electrostatic potential of RNA double helices: An application on tRNA acceptor stems
Ray Marcel Marín, Universidad Nacional de Colombia
P-67 : A graph theoretical approach to compare molecular electrostatic potentials
Ray Marcel Marín, Universidad Nacional de Colombia
P-68 : Engineering polymer informatics
Nico Adams, University of Cambridge
P-69 : Information extraction from the polymer literature
Lezan Hawizy, University of Cambridge
Presentation (0.9 MB)
P-70 : MeFc and large chemical data sets
Hamse Y. Mussa, University of Cambridge
P-71 : Kernel based least squares and large data sets
Hamse Y. Mussa, University of Cambridge
P-72 : Molecular spam: Use of a modified spam filter for classification of bioactive molecules and drug target prediction
Florian Nigsch, University of Cambridge
P-73 : SPECTRa-T: Machine-based data extraction and semantic searching of chemistry e-theses
Joseph Andrew Townsend, University of Cambridge
P-74 : Creating chemo- & bioinformatics workflows: Further developments within the CDK-Taverna project
Thomas Kuhn, University of Cologne
P-75 : Protein-Protein interactions as targets for drugs: A view from the binding site
Richard M. Jackson, University of Leeds
P-76 : Determinants for selectivity in map kinase inhibitors by computational simulations
Nikita Basant, University of Modena and Reggio Emilia
P-77 : Fragment weighting schemes for similarity-based virtual screening: Use of occurrence weighting
Shereen Arif, University of Sheffield
P-78 : Effect of data standardization on the clustering of chemical structures
Chia-Wei Chu, University of Sheffield
P-79 : Multiobjective optimisation of pharmacophore hypotheses: Bias towards low-energy conformations
Val Gillet, University of Sheffield

P-80 : Weighted data fusion with turbo similarity searching to improve chemical similarity searching
John Holliday, University of Sheffield
Presentation (0.2 MB)

P-81 : Using wavelets to represent GRID fields in virtual screening
Richard Martin, University of Sheffield
P-82 : A multiobjective approach to scoring functions for docking
Iain Peter Mott, University of Sheffield
P-83 : Neighbourhood behaviour studies for lead optimisation
Georgios Papadatos, University of Sheffield
Presentation (0.5 MB)

P-84 : Maximum unbiased validation (MUV) datasets for virtual screening by PubChem based chemogenomics data mining
Sebastian Georgios Rohrer, University of Technology Braunschweig
Presentation (1.6 MB)

P-85 : 3D-Visualization of molecular conformations in the MOGADOC database
Jürgen Vogt, University of Ulm
P-86 : Similarity based correction for the predictions of compounds physicochemical properties
Andrius Sazonovas, Vilnius University
Presentation (0.7 MB)
P-87 : Prediction of ionization constants for complex multicenter electrolytes utilizing proprietary ‘in house’ data
Andrius Sazonovas, Vilnius University
Presentation (0.7 MB)
P-88 : A novel chemical database for sustainable development of synthesis routes - An instance of developing synthesis routes of quinolone derivatives
Kenzi Hori, Yamaguchi University
P-89 : Combinatrial chemistry using theoretical calculations: An application to boric acid catalyzed esterification of phenol
Maki Shimeno, Yamaguchi University
P-90 : Calculation of difference of free energy of solvations using the QM/MC/FEP method in chemical reactions
Keita Uezu, Yamaguchi University
P-91 : Toward in silico screening using transition state data base for developing new synthesis routes
Toru Yamaguchi, Yamaguchi University
P-92 : Tautomer generation. pKa based dominance conditions for generating the dominant tautomers
Ferenc Csizmadia, ChemAxon Ltd.
Presentation (0.8 MB)
P-93 : Chemical terms – A language for cheminformatics
Akos Papp, ChemAxon
Presentation (1.1 MB)